Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eiichiro Toyokawa
Observed names:
E. Toyokawa,
Eiichirou Toyokawa
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
ORCID:
0009-0007-8220-0282
Observed ORCID:
0009-0007-8220-0282
OpenAlex ID:
A5122813110
Paradigm Shifts in Perioperative Management of Colorectal Cancer: Personalization Based on Tumor Biology, Primary Site, and Recurrence Risk, and the Evolving Role of Organ Preservation
2026
·
Kaoru Yoshikawa
, Akira Ooki
, et al.
·
International Journal of Molecular Sciences
·
1
New Compass for Precision Oncology: Evidence, Challenges, and Prospects of Circulating Tumor DNA in Colorectal Cancer
2026
·
Keito Suzuki
, Akira Ooki
, et al.
·
Cancer Control
·
1
A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA
2026
·
Eiichiro Toyokawa
, Akira Ooki
, et al.
·
Biomolecules
·
1
PDF
Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy
2026
·
A. Ooki
, K. Nakano
, et al.
·
ESMO Gastrointestinal Oncology
·
1
PDF
92P Circulating tumor DNA RAS mutant allele frequency as a predictor of efficacy of anti-EGFR monoclonal antibody rechallenge in patients with metastatic colorectal cancer
2026
·
E. Toyokawa
, H. Osumi
, et al.
·
Annals of Oncology
Author response for "New Compass for Precision Oncology: Evidence, Challenges, and Prospects of Circulating Tumor DNA in Colorectal Cancer"
2026
·
Keito Suzuki
, Akira Ooki
, et al.
·
Publons reviews and discussion
Author response for "New Compass for Precision Oncology: Evidence, Challenges, and Prospects of Circulating Tumor DNA in Colorectal Cancer"
2026
·
Keito Suzuki
, Akira Ooki
, et al.
·
Publons reviews and discussion
Prognostic value of KRAS exon 3, exon 4, and NRAS mutations in pathological stage III colon cancer.
2026
·
Kaoru Yoshikawa
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
PDF
Clinical significance of serum tumor marker dynamics during preoperative chemotherapy and hepatectomy for colorectal liver metastases.
2026
·
Shohei Udagawa
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
PDF
Prognostic impact of RAS/BRAF mutations and clinical factors in 441 patients undergoing pulmonary metastasectomy for colorectal cancer.
2026
·
Masahiro Kuno
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
PDF
Effect of initial corticosteroid doses and second-line immunosuppressants on overall duration of corticosteroid therapy for immune-related adverse events in gastrointestinal tumors.
2026
·
Emiko Tange
, Koichi Takeda
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
11
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type